Individualized prevention of proton pump inhibitor related adverse events by risk stratification

Abstract Proton pump inhibitors (PPIs) are commonly used for gastric acid-related disorders, but their safety profile and risk stratification for high-burden diseases need further investigation. Analyzing over 2 million participants from five prospective cohorts from the US, the UK, and China, we fo...

Full description

Bibliographic Details

Published in:	Nature Communications
Main Authors:	Bin Xia, Qiangsheng He, Fang Gao Smith, V. Georgios Gkoutos, Krishnarajah Nirantharakumar, Zi Chong Kuo, Danni Wang, Qi Feng, Eddie C. Cheung, Lunzhi Dai, Junjie Huang, Yuanyuan Yu, Wenbo Meng, Xiwen Qin, Jinqiu Yuan
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-04-01
Online Access:	https://doi.org/10.1038/s41467-024-48007-8